Indoco Remedies Reports Improved Q1 FY27 Revenue and EBITDA
Indoco Remedies reported higher revenue and improved EBITDA in Q1 FY27, supported by the strong performance of its domestic formulations business and steady progress in international formulations and APIs.
Finished Dosage Formulation | 28/07/2026 | By News Bureau
Laurus Labs Posts Strong Q1 FY26 Results With 31 Percent Revenue Growth
Laurus Labs has reported strong financial results for the first quarter of FY26, with consolidated revenues reaching INR 1,570 crore—a 31 percent year-on-year increase.
Finished Dosage Formulation | 26/07/2025 | By Dineshwori | 1934
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy